Onyx soars after rebuffing Amgen bid


Amgen Not Offering Enough

Onyx Pharmaceuticals said it rejected a $120-a-share takeover offer at the hands of Amgen, saying the bid "significantly undervalued" its business. The company now plans to seek other buyers. ONXX, which closed at $86.82 on Friday, rockets 51 percent before the bell on my tradeMONSTER platform!

InterDigital Lower on Patent Ruling

InterDigital lost a patent ruling in a preliminary decision by the International Trade Commission. The ruling affects mobile technology and favored overseas companies including Nokia. IDCC is down 18 percent in early trading.

Research in Motion Falls on Morgan Downgrade

Research in Motion plunged on Friday following weak results. Now Morgan Stanley is adding insult to injury, downgrading the handset maker to "equal weight" from "overweight." BBRY is down 5 percent in the pre.

More From optionMONSTER
View Comments (0)